XNCR (Xencor, Inc.) Bozor qiymatining balans qiymatiga nisbati

Xencor, Inc. (XNCR) kompaniyasining rasmiy ramzlari

Xencor, Inc. o'z platformasini rivojlantirish uchun yirik sog'liqni saqlash gigantlari bilan keng ittifoqlar tarmog'idan foydalangan holda innovatsion o'simtaga qarshi agentlarni ishlab chiqadi. Ushbu grafik XNCR ( 4.45 ) narxining harakatini aks ettiradi. Kompaniya yangi dori vositalarining klinik sinovlari orqali bozordagi mavjudligini kengaytirishga intilmoqda; biroq, yuqori tadqiqot xarajatlari va tashqi moliyalashtirishga bog'liqlik tufayli uning moliyaviy bazasi beqarorligicha qolmoqda.

Xencor Inc. (XNCR): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha
Xencor Corp brendining mahsuloti

Emitentni xolis baholash uchun menejer biznesning haddan tashqari qimmat baholanganlik darajasini aniqlash maqsadida joriy aksiya narxini sof aktivlarning haqiqiy qiymati bilan solishtirishi kerak. Narxning buxgalteriya qiymatiga nisbati grafigini tahlil qilish orqali investor Xencor, Inc. (XNCR) uchun intellektual kapital mukofotini aniqlashi mumkin, uning noyob protein muhandisligi platformasi va saraton terapiyasi sohasidagi nufuzi bozor diskontini yoki premiumini asoslaydi.

Raqobatchilar tahlili

Bozor qiymatining balans qiymatiga nisbati ImmunityBio, Inc. IBRX|IMCR (immunocore.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati JANX (Janux Therapeutics, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti RCUS|Bozor qiymatining balans qiymatiga nisbati Zymeworks Corp ZYME|Kapitallashuvning balans qiymatiga nisbati Tango Therapeutics Corp (TNGX)|Iovance Biotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|immatics.com - Kapitallashuvning sof aktivlarga nisbati|CMPX (Compass Therapeutics, Inc.) - Bozor qiymatining balans qiymatiga nisbati|REPL: Bozor qiymatining balans qiymatiga koeffitsiyenti|Lyell Immunopharma Inc (LYEL) - Bozor qiymatining balans qiymatiga nisbati|IPHA (Innate Pharma S.A) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati PYXS (Pyxis Oncology Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Compugen Limited|IOBT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Sutro Biopharma Inc. STRO|INKT: Kapitallashuvning sof aktivlarga nisbati|HOWL - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Immix (IMMX)|ALXO - Balans qiymatiga nisbatan bozor qiymati|Cue Biopharma - Bozor kapitallashuvining balans qiymatiga nisbati|PDSB (PDS Biotechnology Corporation) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati SONN|Kapitallashuvning sof aktivlarga nisbati MAIA|Bozor qiymatining balans qiymatiga nisbati LIMN (Liminatus Pharma)|Kapitallashuvning sof aktivlarga nisbati lavatherapeutics.com LVTX|Kapitallashuvning sof aktivlarga nisbati NXTC (NextCure)|Leap Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Intensity Tx (INTS) - Bozor qiymatining balans qiymatiga nisbati|SNSE: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati TOVX|Bozor qiymatining balans qiymatiga koeffitsiyenti Gritstone bio|Kineta - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining xususiy kapitalga nisbati NexImmune Inc (NEXI)|Kapitallashuvning sof aktivlarga nisbati Turnstone Biologics|Bozor kapitallashuvining balans qiymatiga multiplikatori Vaccinex Inc (VCNX)|Bozor kapitallashuvining balans qiymatiga nisbati Harpoon Therapeutics